According to Markntel Advisors Report, Topical
Pain Relief Market is expected to grow at a significant growth rate, and the
analysis period is 2023-2028,
considering the base year as 2022.Consistent
monitoring and evaluating of market dynamics to stay informed and adapt your
strategies accordingly. As a market research and consulting firm, we offer
market research reports that focus on major parameters including Target Market
Identification, Customer Needs and Preferences, Thorough Competitor Analysis,
Market Size & Market Analysis, and other major factors. At the end, we do
provide meaningful insights and actionable recommendations that inform
decision-making and strategy development.
Topical pain relief
medications are medications applied directly to the epidermal layer of skin at
and around the area of inflammation or pain. It includes painkillers, directly
applied, sprayed, or rubbed on the skin over painful muscles or joints. Such
relief medications are analgesic or anesthetic formulations designed to relieve
pain and use skin as the path for drug administration and exert major action at
the targeted site and in the central nervous system. The medication aims to
offer a slow and gradual release of pain relief medication into the bloodstream
by keeping the blood levels relatively constant for some time while, offering
lesser side effects than oral medication.
Global Topical Pain
Relief Market Research Report & Summary:
The Global Topical Pain Relief Market was
valued at USD 9.5 Billion 2022 and is projected to grow at a CAGR of around
7.5% during the forecast period, i.e.,
2023-28.
Time
Period Captured in the Report:
·
Historical
Years: 2018-21
·
Base
Years: 2022
·
Forecast
Years: 2023-28
Who are the Key Players Operating in
the Topical Pain Relief Market?
The top
companies of the Topical Pain Relief Market ruling the industry are:
AdvaCare
Pharma, GlaxoSmithKline plc., Sanofi, Johnson & Johnson, Novartis AG,
Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc.,
Topical BioMedics, Inc. (Topricin), Exzell Pharma, Emami Group
✅In case you missed it, we are
currently revising our reports. Click on the below to get the latest research
data with forecast for years 2025 to 2030, including market size, industry
trends, and competitive analysis. It wouldn’t take long for the team to deliver
the most recent version of the report.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/global-topical-pain-relief-market.html
("Kindly use your official email ID for all correspondence to
ensure seamless engagement and access to exclusive benefits, along with
prioritized support from our sales team.")
What is Included in Topical Pain
Relief Market Segmentation?
The Topical Pain Relief Market explores the
industry by emphasizing the growth parameters and categorizes including
geographical segmentation, to offer a comprehensive understanding of the market
dynamic. The further bifurcations are as
follows:
- By Type
- Prescription Pain Relief
- Over-The-Counter Pain Relief
- By Therapeutic Class
- Non-Opioids
- Nonsteroidal Anti-Inflammatory Drug
- Methyl Salicylate
- Capsaicin
- Lidocaine
- Opioids
- Buprenorphine
- Fentanyl
- By Formulation
- Cream
- Gel
- Spray
- Patch
- By Distribution Channel
- Pharmacy Drug Store
- E-Commerce
- Others
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Explore the Complete Topical Pain Relief Market Analysis Report – https://www.marknteladvisors.com/research-library/global-topical-pain-relief-market.html
Global Topical Pain Relief Market Dynamics:
Key Driver: Growing Prevalence of
Arthritis, Chronic Disease, And Diabetic Neuropathy
There has been a significant
rise in arthritis, other bone-related conditions, and also diabetic neuropathy
among people, which is driving the adoption of topical therapeutics, thus
acting as the key driver of the topical pain relief market. With the increasing
number of people with joint pain problems, especially as the older generation
population is increasing, the market is likely to expand further. Also, topical
therapeutics provide instant comfort to people with injuries. So, the perpetual
amount of accidents in the daily life of people also in various industries is
likely to fuel the market growth.
Possible Restraint: Side Effects Associated
with Topical Pain Relief Products
Though opioids
are used usually in joint and pain treatment including, back pain, muscle
tenderness, headache, and also in pain associated with cancer ailments, these
medications also pose some hazardous side effects such as nausea, mild
concussions, breathing complications, and more. Also, the unpleasant odor of
such topical therapeutics is disliked and could cause nausea or irritation in
the eyes and nose, along with skin irritation. The expanding knowledge and
awareness about such side-effects are likely to restrain the market growth.
Need
personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/global-topical-pain-relief-market.html
Why Markntel Advisor Report?
MarkNtel Advisors is a leading consulting, data
analytics, and market research firm that provides an extensive range of
strategic reports on diverse industry verticals. We being a qualitative &
quantitative research company, strive to deliver data to a substantial &
varied client base, including multinational corporations, financial
institutions, governments, and individuals, among others.
We have our existence across the market for
many years and have conducted multi-industry research across 80+ countries,
spreading our reach across numerous regions like America, Asia-Pacific, Europe,
the Middle East & Africa, etc., and many countries across the regional
scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil,
and several others.
For Further
Queries:
Contact Us
MarkNtel
Advisors
Email at -sales@marknteladvisors.com
Corporate
Office: Office No.109, H-159,
Sector 63, Noida, Uttar Pradesh - 201281, India
Comments
0 comment